C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/30 (2006.01) A61K 39/395 (2006.01)
Patent
CA 2655289
The present invention relates to an antibody or a fragment thereof which is capable of binding to a Frizzled homologue 10 (FZD10) protein, such as a mouse monoclonal antibody, a chimeric antibody and a humanized antibody. Also, the present invention relates to a method for treating and/or preventing FZD10-associated disease; a method for diagnosis or prognosis of FZD10-associated disease; and a method for in vivo imaging of FZD10 in a subject.
La présente invention concerne un anticorps ou un fragment de cet anticorps qui est susceptible de se lier à une protéine homologue Frizzled 10 (FZD10), tel qu'un anticorps monoclonal de souris, un anticorps chimérique et un anticorps humanisé. La présente invention concerne également un procédé destiné au traitement et/ou à la prévention d'une maladie associée à la FZD10, un procédé permettant de diagnostiquer ou de pronostiquer une maladie associée à la FZD10, et un procédé de technique d'imagerie in vivo de la FZD10 chez un sujet.
Endo Keigo
Katagiri Toyomasa
Kuhara Motoki
Nakamura Yusuke
Nakatsuru Shuichi
Oncotherapy Science Inc.
Smart & Biggar
LandOfFree
Tumor-targeting monoclonal antibodies to fzd10 and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor-targeting monoclonal antibodies to fzd10 and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor-targeting monoclonal antibodies to fzd10 and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1828038